a provider of outsourced clinical development and commercialization services to biopharmaceutical companies
Industry PharmaceuticalsOther
A.I.dvisor tells us that INCR and PHCUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and PHCUF's prices will move in lockstep.
Ticker / NAME | Correlation To INCR | 1D Price Change % | ||
---|---|---|---|---|
INCR | 100% | -5.12% | ||
PHCUF - INCR | 26% Poorly correlated | N/A | ||
CRON - INCR | 24% Poorly correlated | -4.61% | ||
CGC - INCR | 23% Poorly correlated | -5.08% | ||
TLRY - INCR | 22% Poorly correlated | -4.17% | ||
QNTM - INCR | 22% Poorly correlated | -0.95% | ||
More |
Ticker / NAME | Correlation To INCR | 1D Price Change % |
---|---|---|
INCR | 100% | -5.12% |
biopharmaceuticals theme (50 stocks) | 15% Poorly correlated | -2.60% |
health theme (30 stocks) | 10% Poorly correlated | -1.94% |
Pharmaceuticals theme (308 stocks) | 7% Poorly correlated | -1.29% |
Pharmaceuticals: Other theme (235 stocks) | 1% Poorly correlated | -1.52% |